Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
0.3600
+0.0340 (10.43%)
At close: Mar 20, 2026, 4:00 PM EDT
0.3343
-0.0257 (-7.14%)
After-hours: Mar 20, 2026, 7:03 PM EDT

Silo Pharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
0.070.070.070.070.07-
Revenue Growth (YoY)
---1.18%--
Cost of Revenue
0.030.010.010.010.01-
Gross Profit
0.050.070.070.070.07-
Selling, General & Admin
2.422.43.082.412.122.18
Research & Development
2.932.370.851.290.690.03
Total Operating Expenses
5.354.773.923.692.812.2
Operating Income
-5.31-4.71-3.86-3.63-2.74-2.2
Interest Income
0.230.330.40.0700.01
Interest Expense
-0-0.01-0-0-0-0.27
Other Non-Operating Income (Expense)
0.230.30.06-0.6313.85-0.67
Total Non-Operating Income (Expense)
0.460.630.45-0.5613.85-0.93
Pretax Income
-5.08-4.39-3.63-3.914.18-2.67
Provision for Income Taxes
----0.02-
Net Income
-5.08-4.39-3.77-7.542.5-3.11
Net Income Attributable to Preferred Dividends
----1.40.07
Earnings From Discontinued Operations
---0.14-0-0.51-0.37
Net Income to Common
-5.08-4.39-3.77-7.542.5-3.11
Shares Outstanding (Basic)
643221
Shares Outstanding (Diluted)
643221
Shares Change (YoY)
87.39%19.50%34.83%19.07%45.44%181.03%
EPS (Basic)
-0.95-1.19-1.20-1.711.45-2.07
EPS (Diluted)
-0.95-1.19-1.20-1.711.43-2.07
Free Cash Flow
-4.8-3.83-3.22-3.5-2.28-1.16
Free Cash Flow Per Share
-0.78-1.04-1.05-1.53-1.19-0.88
Gross Margin
65.24%91.90%91.90%91.90%92.98%-
Operating Margin
-7361.09%-6526.44%-5347.41%-5031.28%-3850.95%-
Profit Margin
-7041.12%-6092.59%-5036.04%-10450.53%1982.44%-
FCF Margin
-6655.15%-5317.35%-4472.13%-4850.94%-3196.59%-
EBITDA
-5.3-4.7-3.86-3.63-2.74-2.2
EBITDA Margin
-7345.00%-6517.86%-5347.41%-5031.28%-3850.95%-
EBIT
-5.31-4.71-3.86-3.63-2.74-2.2
EBIT Margin
-7361.09%-6526.44%-5347.41%-5031.28%-3850.95%-
Effective Tax Rate
-0.00%0.00%0.00%0.59%0.00%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q